Press Release DarkPulse Inc. Announces Plan for an IPO of its Subsidiary, Optilan, on the New York Stock Exchange
6th January 2022
NEW YORK, January 6, 2022 DarkPulse Inc. (OTC: DPLS) (“DPLS” or “the Company”), with the full support of its board of directors, today announced its intention to take its wholly-owned subsidiary, Optilan (“Optilan”), public in the U.S. in mid-2022 via an initial public offering (IPO). Management believes the move will unlock the…
Read More